Maternal plasma advanced glycation end products concentrations in response to oral 50-gram glucose load in mid-pregnancy: A pilot study

Clinical Laboratory

Volumn 58, Issue 9-10, 2012, Pages 1045-1050

  Williams, Michelle A ^a,b,c   Enquobahrie, Daniel A ^b,c   Zimmer, Jennifer ^d   Qiu, Chun Fang ^b   Hevner, Karin ^b   Abetew, Dejene ^b   Christianson, Chad ^d   Sheaff, Chrystal ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b SWEDISH MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Alturas Analytics Incorporated   (United States)

Author keywords

Methylglyoxal (MG); Mid pregnancy; N (carboxymethyl) lysine (CML); Oral glucose load; Pentosidine; Plasma advanced glycation end products (AGEs)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; MASS SPECTROMETRY; MATERNAL PLASMA; ORAL GLUCOSE TOLERANCE TEST; PILOT STUDY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PROSPECTIVE STUDY;

ADULT; ARGININE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; LYSINE; MASS SPECTROMETRY; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; PYRUVALDEHYDE;

EID: 84868584480     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.111219     Document Type: Article

References (25)

1. ADA. Diagnosis and classification of diabetes mellitus. Diabetes care 2010;33 Suppl 1:S62-9.
2. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstetrics and Gynecology 2004;103(3):526-33. (Pubitemid 40459069)
3. Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31(5):899-904.
4. Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998;21 Suppl 2:B19-26. (Pubitemid 28357028)
5. Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetic Medicine : A Journal of the British Diabetic Association 2004;21(2):103-113.
6. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstetrics and Gynecology 2003;102(4):850-6. (Pubitemid 37206424)
7. Maffei M, Volpe L, Di Cianni G, et al. Plasma leptin levels in newborns from normal and diabetic mothers. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 1998;30(9):575-80.
8. Enquobahrie DA, Qiu CF, Hevner K, Abetew D, Williams MA. Maternal plasma protein profiles in response to oral 50-gram glucose load in mid-pregnancy: a pilot study. International Journal of Molecular Epidemiology and Genetics 2011;2(3):292-9.
9. Losser MR, Bernard C, Beaudeux JL, Pison C, Payen D. Glucose modulates hemodynamic, metabolic, and inflammatory responses to lipopolysaccharide in rabbits. J Appl Physiol 1997;83(5):1566-74. (Pubitemid 27495332)
10. Qiu C, Frederick IO, Zhang C, Sorensen TK, Enquobahrie DA, Williams MA. Risk of gestational diabetes mellitus in relation to maternal egg and cholesterol intake. American Journal of Epidemiology 2011;173(6):649-58.
11. Enquobahrie DA, Williams MA, Qiu C, Luthy DA. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Research and Clinical Practice 2005;70(2):134-42. (Pubitemid 41368061)
12. Han Y, Randell E, Vasdev S, et al. Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Molecular and Cellular Biochemistry 2007;305(1-2):123-31. (Pubitemid 47517175)
13. Teerlink T, Barto R, Ten Brink HJ, Schalkwijk CG. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl) lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clinical Chemistry 2004;50(7):1222-8.
14. Ni J, Yuan X, Gu J, et al. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration. Molecular & Cellular Proteomics MCP 2009;8(8):1921-33.
15. Wang H, Meng QH, Gordon JR, Khandwala H, Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clinical Biochemistry 2007;40(16-17):1232-9. (Pubitemid 47562425)
16. Chang T, Wu L. Methylglyoxal, oxidative stress, and hypertension. Canadian Journal of Physiology and Pharmacology 2006;84(12):1229-38. (Pubitemid 46707370)
17. Desai KM, Chang T, Wang H, et al. Oxidative stress and aging: is methylglyoxal the hidden enemy? Canadian Journal of Physiology and Pharmacology 2010;88(3):273-84.
18. Fleming TH, Humpert PM, Nawroth PP, Bierhaus A. Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review. Gerontology 2011;57(5):435-43.
19. Ikeda K, Higashi T, Sano H, et al. N (epsilon)-(carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996;35(24):8075-83.
20. Ledl F, Schleicher E. New Aspects of the Maillard Reaction in Foods and in the Human Body. Angew Chem Int Ed Engl 1990;29:565-94.
21. Shaham O, Wei R, Wang TJ, et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Molecular Systems Biology 2008;4:214.
22. Zhao X, Peter A, Fritsche J, et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at? American Journal of Physiology Endocrinology and Metabolism 2009;296(2):E384-93.
23. Shankar R, Gude N, Cullinane F, Brennecke S, Purcell AW, Moses EK. An emerging role for comprehensive proteome analysis in human pregnancy research. Reproduction 2005;129(6):685-96. (Pubitemid 40872820)
24. Graca G, Duarte IF, Barros AS, et al. Impact of prenatal disorders on the metabolic profile of second trimester amniotic fluid: a nuclear magnetic resonance metabonomic study. Journal of Proteome Research 2010;9(11):6016-24.
25. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 2002;123(4):487-95. (Pubitemid 34303150)